Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
0.4228
-0.0272 (-6.04%)
At close: Jun 6, 2025, 4:00 PM
0.4300
+0.0072 (1.70%)
After-hours: Jun 6, 2025, 7:26 PM EDT
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $26.28 million as of June 6, 2025. Its market cap has decreased by -67.46% in one year.
Market Cap
26.28M
Enterprise Value
-11.96M
1-Year Change
-67.46%
Ranking
Category
Stock Price
$0.42
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $26.28M, a decrease of -97.25%. That is a compound annual growth rate of -49.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 27.97M | -20.16% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | 1.16B | 21.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.15B |
| Johnson & Johnson | 373.01B |
| AbbVie | 335.32B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.06B |
| Abbott Laboratories | 232.41B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.14B |